Anti-myocardial ischemia

Tetrahydroberberine
Catalog No: CFN90506

Tetrahydroberberine, with D(2) receptor antagonist and 5-HT(1A) receptor agonist properties, has significant potential as a therapeutic for treatment of FD; it has antidopaminergic effect, and other pharmacological action on the central nervous system. Tetrahydroberberine can inhibit the rabbit platelet aggregation.

1beta-Hydroxyalantolactone
Catalog No: CFN92600

1beta-Hydroxyalantolactone has protective effect against AD-like skin inflammation, can as a potential therapeutic agent for AD.

Osajin
Catalog No: CFN97917

Osajin shows antitumor activity in different tumor cell lines, it induces apoptosis in human NPC cells through multiple apoptotic pathways, including the extrinsic death receptor pathway, and intrinsic pathways relying on mitochondria and endoplasmic reticulum stress. The cardioprotection provided by Osajin treatment results from the suppression of oxidative stress and correlates with the improved ventricular function.